Kalpana Tilekar - Concepedia

Author

Kalpana Tilekar

Bharati Vidyapeeth Deemed University ORCID

Also Known As

Kalpana N. Tilekar, Kalpana Tilekar

Publications

669

Citations

H-Index

Concepts

All Affiliations

Bharati Vidyapeeth Deemed University Technical University of Darmstadt The University of Texas at El Paso University of Naples Federico II East Carolina University

About

Kalpana Tilekar is an author at Bharati Vidyapeeth Deemed University specializing in pharmacology, drug discovery, and drug development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	312
2	Natural Sciences	6	6	160
3	Biochemistry	5	5	119
4	Biomolecular Engineering	3	3	88
5	Chemical Biology	2	2	21

Kalpana Tilekar

Publications

568

Citations

H-Index

Page 1

	Year	Citations
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives Vijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj, European Journal of Medicinal Chemistry DerivativesNew 5-Benzylidene-2,4-thiazolidinedioneOrganic ChemistryHeterocycle ChemistryPharmacology	2010	138
Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation Neha Upadhyay, Kalpana Tilekar, Niklas Jänsch, Bioorganic Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural Sciences	2020	48
Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines Kalpana Tilekar, Neha Upadhyay, Niklas Jänsch, Bioorganic Chemistry Selective Hdac8 InhibitorsMedicine5-Naphthylidene-2,4-thiazolidinedione DerivativesPharmacological AgentPharmacotherapy	2019	46
Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery Kalpana Tilekar, Onkar Shelke, Neha Upadhyay, Journal of Molecular Structure Medicinal ChemistryBioorganic ChemistryPolymer-drug ConjugateMedicineNatural Sciences	2021	41
Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy Neha Upadhyay, Kalpana Tilekar, Fulvio Loiodice, Bioorganic Chemistry MedicineDrug DiscoveryRational Drug DesignPharmacological AgentPharmacotherapy	2020	37
Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells Kalpana Tilekar, Neha Upadhyay, Markus Schweipert, European Journal of Pharmaceutical Sciences Medicinal ChemistryMedicineImmunologyGlut InhibitorsPharmacological Agent	2020	36
Thiazolidinedione “Magic Bullets” Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their <i>In Vitro</i> and <i>In Vivo</i> Antitumor Effects Kalpana Tilekar, Jessica D. Hess, Neha Upadhyay, Journal of Medicinal Chemistry	2021	36
Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine‐2,5‐dione Hybrids as Potential Antitumor Agents Kalpana Tilekar, Neha Upadhyay, Franz‐Josef Meyer‐Almes, ChemMedChem	2020	35
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential Kalpana Tilekar, Neha Upadhyay, Jessica D. Hess, European Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryDerivative (Chemistry)BiochemistryGlut 4	2020	33
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, RSC Medicinal Chemistry	2021	21

Page 1